Complement activation increases phagocytosis via opsonization with C3 fragments, promotes inflammation via the generation of complement anaphylatoxins C3a and C5a, and induces direct CML of susceptible pathogens via the generation of the C5b-C9 membrane attack complex. The gene discussed is C5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.